Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Forecast & Target Price

View the latest analyst price targets and forecasts to stay informed on market expectations. Click here to open.

ACHV

Achieve Life Sciences Inc

Dec 02 • 04:00PM ET

4.38

Dollar change -0.03
Percentage change -0.68	%

Healthcare • Biotechnology • Canada • NASD

Peers: ARWR GERN IMMP SGMO ANIP AMRN ALDX ATRA AXSM CRBP

| Held by: VTI IWM VXF SURI IWO VTWO IWN IWC VTWG RSSL

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.13	Insider Own	19.78%	Shs Outstand	34.39M	Perf Week	2.10%
Market Cap	150.63M	Forward P/E	-	EPS next Y	-1.16	Insider Trans	0.00%	Shs Float	27.59M	Perf Month	-6.41%
Income	-32.94M	PEG	-	EPS next Q	-0.34	Inst Own	48.84%	Short Float	10.87%	Perf Quarter	1.15%
Sales	0.00M	P/S	-	EPS this Y	18.58%	Inst Trans	-5.77%	Short Ratio	27.82	Perf Half Y	-15.93%
Book/sh	0.91	P/B	4.80	EPS next Y	5.02%	ROA	-91.19%	Short Interest	3.00M	Perf Year	-24.35%
Cash/sh	1.25	P/C	3.51	EPS next 5Y	-	ROE	-186.03%	52W Range	3.03 - 5.96	Perf YTD	6.31%
Dividend Est.	-	P/FCF	-	EPS past 5Y	53.91%	ROI	-79.96%	52W High	-26.51%	Beta	1.59
Dividend TTM	-	Quick Ratio	6.78	Sales past 5Y	0.00%	Gross Margin	-	52W Low	44.55%	ATR (14)	0.20
Dividend Ex-Date	-	Current Ratio	6.78	EPS Y/Y TTM	46.27%	Oper. Margin	0.00%	RSI (14)	43.62	Volatility	3.82% 4.72%
Employees	22	Debt/Eq	0.31	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	15.56
Option/Short	Yes / Yes	LT Debt/Eq	0.31	EPS Q/Q	-8.26%	Payout	-	Rel Volume	1.00	Prev Close	4.41
Sales Surprise	-	EPS Surprise	-32.50%	Sales Q/Q	-	Earnings	Nov 07 AMC	Avg Volume	107.82K	Price	4.38
SMA20	-3.02%	SMA50	-7.03%	SMA200	-5.97%	Trades		Volume	108,189	Change	-0.68%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-14-24	Initiated	Rodman & Renshaw	Buy	$12
Sep-27-24	Initiated	Raymond James	Strong Buy	$20
May-10-23	Reiterated	Maxim Group	Buy	$8 → $20
Jun-23-21	Initiated	Oppenheimer	Outperform	$23

Nov-14-24 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-08-24 02:01PM	Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -7.40%
Nov-07-24 04:05PM	Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Oct-24-24 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024 (GlobeNewswire)
Oct-23-24 08:00AM	Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting (GlobeNewswire)
08:00AM	Loading…
Oct-16-24 08:00AM	Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline (GlobeNewswire)
Oct-10-24 08:00AM	Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting (GlobeNewswire)
Oct-01-24 08:45AM	Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs (GlobeNewswire)
Aug-26-24 04:30PM	Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors (GlobeNewswire)
Aug-13-24 04:01PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Jul-31-24 08:00AM	Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence (GlobeNewswire)
Jul-29-24 08:00AM	Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank (GlobeNewswire)
Jul-25-24 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024 (GlobeNewswire)
Jul-15-24 08:00AM	Milestone Pharmaceuticals Refreshes Board of Directors (GlobeNewswire)
Jul-09-24 08:00AM	Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024 (GlobeNewswire)
08:00AM	Loading…
Jul-01-24 08:00AM	Achieve Life Sciences Announces Addition to the U.S. Russell 3000 and Russell Microcap Indexes (GlobeNewswire)
May-29-24 08:00AM	Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes (GlobeNewswire)
May-17-24 08:00AM	Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting (GlobeNewswire)
May-13-24 08:55AM	Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating (MT Newswires)
May-10-24 03:47PM	Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results (GuruFocus.com)
12:41PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 04:01PM	Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update (GlobeNewswire)
May-06-24 11:16AM	Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 08:00AM	Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024 (GlobeNewswire)
Apr-11-24 08:00AM	Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference (GlobeNewswire)
Apr-01-24 03:30PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-29-24 06:24AM	Q4 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 08:53PM	ACHV Stock Earnings: Achieve Life Sciences Beats EPS for Q4 2023 (InvestorPlace)
05:32PM	Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval (GuruFocus.com)
04:01PM	Loading…
04:01PM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update (GlobeNewswire)
Mar-20-24 08:00AM	Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire)
Mar-14-24 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024 (GlobeNewswire)
Mar-08-24 08:35AM	Life Science Virtual Investor Forum Presentations Now Available for Online Viewing (GlobeNewswire)
Mar-06-24 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Mar-05-24 08:35AM	Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024 (GlobeNewswire)
Feb-29-24 08:01AM	Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission (GlobeNewswire) -9.19%
08:00AM	Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
Dec-15-23 08:35AM	Life Science Investor Forum: Presentations Now Available for Online Viewing (GlobeNewswire)
Dec-13-23 08:00AM	TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors (GlobeNewswire) +5.40%
Dec-12-23 01:02PM	Life Science Investor Forum Agenda Announced for December 14th, 2023 (GlobeNewswire) -42.20%
09:10AM	Why Is Achieve Life Sciences (ACHV) Stock Down 25% Today? (InvestorPlace)
Dec-11-23 04:30PM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-11-23 10:36AM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 10:01AM	Q3 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-09-23 04:00PM	Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update (GlobeNewswire)
Oct-26-23 08:00AM	Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023 (GlobeNewswire)
Oct-03-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Sep-11-23 08:00AM	Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting (GlobeNewswire)
Sep-07-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire) -5.24%
Aug-16-23 10:30AM	ACHV: 2Q:23 Results (Zacks)
Aug-15-23 10:25PM	Q2 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 04:00PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update (GlobeNewswire)
Aug-01-23 08:00AM	Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast (GlobeNewswire)
Jul-18-23 08:00AM	Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting (GlobeNewswire)
Jul-11-23 11:23AM	Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA) (GlobeNewswire)
May-25-23 09:00AM	Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering (GlobeNewswire) -6.07%
07:16AM	ACHV: ORCA-3 Topline (Zacks Small Cap Research)
May-24-23 06:10AM	Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Shift From Loss To Profit (Simply Wall St.)
May-23-23 02:46PM	Can't Kick the Bud? Achieve's Cytisinicline Proves Promising in Phase 3 Smoking Cessation Trial (Benzinga) -23.80%
06:00AM	Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial (GlobeNewswire)
May-17-23 08:00AM	Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank (GlobeNewswire)
May-10-23 09:08AM	ACHV: First Quarter Results (Zacks Small Cap Research) +12.71%
05:57AM	Q1 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-23 04:05PM	Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update (GlobeNewswire)
Apr-26-23 08:00AM	Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023 (GlobeNewswire)
Apr-24-23 05:27AM	ACHV: ORCA-V1 Readout (Zacks Small Cap Research)
Apr-20-23 02:22PM	Want To Quit Smoking? Achieve Life Sciences Reports Successful E-Cigarette Cessation Benefit With Cytisinicline Treatment (Benzinga)
08:00AM	Achieve Life Sciences Announces Positive Phase 2 ORCA-V1 Trial Results Showing Statistically Significant Vaping Cessation Benefit for Participants Treated with Cytisinicline (GlobeNewswire)
Apr-14-23 08:00AM	Achieve Life Sciences to Present at Life Science Innovation Northwest 2023 Conference (GlobeNewswire)
Mar-30-23 08:00AM	Achieve Life Sciences Announces Refresh to Board of Directors (GlobeNewswire) +5.86%
Mar-29-23 08:00AM	Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) +7.57%
Mar-20-23 10:46PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2022 Earnings Call Transcript (Insider Monkey)
05:27AM	ACHV: 2022 Financial and Operational Results (Zacks Small Cap Research)
Mar-17-23 08:00AM	Achieve Life Sciences Announces Granting of New Hire Inducement Award (GlobeNewswire)
05:48AM	Q4 2022 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-16-23 04:05PM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update (GlobeNewswire)
Mar-08-23 08:00AM	Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation (GlobeNewswire)
Mar-03-23 08:00AM	Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire) +7.79%
Mar-02-23 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023 (GlobeNewswire)
Feb-15-23 05:42AM	Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) top owners are individual investors with 56% stake, while 43% is held by institutions (Simply Wall St.) -15.52%
Feb-07-23 08:00AM	Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation (GlobeNewswire)
Feb-02-23 08:00AM	Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-27-23 04:30PM	Achieve Life Sciences Announces Granting of New Hire Inducement Award (GlobeNewswire)
Jan-09-23 08:00AM	Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) +7.28%
Dec-29-22 06:02AM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-21-22 08:00AM	Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation (GlobeNewswire)
Nov-21-22 06:01AM	ACHV: 3Q:22 Results: Target Enrollments Reached (Zacks Small Cap Research)
Nov-15-22 08:00AM	Achieve Life Sciences Announces Private Placement of $18.9 Million (GlobeNewswire) +5.45%
Nov-14-22 04:05PM	Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update (GlobeNewswire)
Nov-08-22 08:00AM	Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial (GlobeNewswire)
Oct-31-22 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022 (GlobeNewswire)
Sep-27-22 08:00AM	Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) -7.42%
Sep-07-22 08:00AM	Achieve Life Sciences Announces Participation at Fall Investor Conferences (GlobeNewswire)
Aug-15-22 06:16AM	ACHV: Autumn Enrollment Completion for ORCA-3 (Zacks Small Cap Research) +12.80%
Aug-11-22 04:05PM	Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update (GlobeNewswire)
Jul-28-22 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022 (GlobeNewswire)
Jul-01-22 04:05PM	Achieve Life Sciences Announces Granting of New Hire Inducement Awards (GlobeNewswire)
Jun-29-22 08:00AM	Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation (GlobeNewswire)
Jun-21-22 08:00AM	Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference (GlobeNewswire)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wan Jerry	Principal Accounting Officer	Apr 19 '24	Option Exercise	0.00	5,625	0	12,057	Apr 23 04:39 PM
JACOBS CINDY	President & CMO	Apr 19 '24	Option Exercise	0.00	16,250	0	34,511	Apr 23 04:35 PM
Stewart Richard Alistair	Executive Chairman	Apr 19 '24	Option Exercise	0.00	22,500	0	61,001	Apr 23 04:31 PM
Bencich John	CEO	Apr 19 '24	Option Exercise	0.00	25,000	0	101,724	Apr 23 04:26 PM
Stewart Richard Alistair	Executive Chairman	Mar 04 '24	Buy	4.58	10,000	45,850	38,501	Mar 06 04:49 PM
Bencich John	CEO	Mar 04 '24	Buy	4.58	10,000	45,850	76,724	Mar 06 04:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACHV

Achieve Life Sciences Inc

Upgrade your FINVIZ experience